Cargando…
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents
Targeting co-stimulatory receptors promotes the activation and effector functions of anti-tumor lymphocytes. 4-1BB (CD137/TNFSF9), a member of the tumor necrosis factor receptor superfamily (TNFR-SF), is a potent co-stimulatory receptor that plays a prominent role in augmenting effector functions of...
Autores principales: | Battin, Claire, De Sousa Linhares, Annika, Leitner, Judith, Grossmann, Anna, Lupinek, Daniela, Izadi, Shiva, Castilho, Alexandra, Waidhofer-Söllner, Petra, Grabmeier-Pfistershammer, Katharina, Stritzker, Jochen, Steinberger, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412504/ https://www.ncbi.nlm.nih.gov/pubmed/37310433 http://dx.doi.org/10.1007/s00262-023-03474-8 |
Ejemplares similares
-
BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022) -
FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab
por: Leitner, Judith, et al.
Publicado: (2023) -
Not All Immune Checkpoints Are Created Equal
por: De Sousa Linhares, Annika, et al.
Publicado: (2018) -
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019) -
PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells
por: Stecher, Carmen, et al.
Publicado: (2017)